.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Citi
Novartis
Farmers Insurance
Moodys
Medtronic
Argus Health
Cerilliant
Accenture

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205436

« Back to Dashboard

NDA 205436 describes SIVEXTRO, which is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the SIVEXTRO profile page.

The generic ingredient in SIVEXTRO is tedizolid phosphate. One supplier is listed for this compound. Additional details are available on the tedizolid phosphate profile page.

Summary for 205436

Tradename:1
Applicant:1
Ingredient:1
Patents:3

Pharmacology for NDA: 205436

Suppliers and Packaging for NDA: 205436

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SIVEXTRO tedizolid phosphate POWDER;IV (INFUSION) 205436 NDA Merck Sharp & Dohme Corp. 67919-040 67919-040-01 10 VIAL, GLASS in 1 CARTON (67919-040-01) > 4 mL in 1 VIAL, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength200MG/VIAL
Approval Date:Jun 20, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:Jun 20, 2024
Regulatory Exclusivity Use:GENERATING ANTIBIOTIC INCENTIVES NOW
Regulatory Exclusivity Expiration:Jun 20, 2019
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:► SubscribePatent Expiration:Feb 23, 2028Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cerilliant
Fuji
Accenture
Express Scripts
Deloitte
McKinsey
Chinese Patent Office
Federal Trade Commission
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot